GlassScriptPhysician profile
Scott Brockman
NPI 1508364084
$3,376.00
in general payments reported to CMS, 2019-2025
28 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.99 · 2020: $219 · 2022: $121 · 2023: $834 · 2024: $1,087 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,951 · Education: $24.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.17 |
| Education | $24.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $622.89 | 2019-2025 | Ams 700, Lithovue, Bulkamid |
| Procept Biorobotics Corporation | $370.97 | 2024-2025 | Aquabeam System |
| Olympus America INC. | $364.63 | 2023-2025 | Itind System, Soltive |
| Sumitomo Pharma America, INC. | $294.07 | 2024-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $240.55 | 2023-2025 | Erleada |
| Urogen Pharma, INC. | $152.06 | 2023-2025 | Jelmyto |
| Teleflex LLC | $142.75 | 2023 | Urolift |
| Abbvie INC. | $120.35 | 2024-2025 | |
| Medtronic, INC. | $118.62 | 2023-2025 | Interstim |
| Myriad Genetic Laboratories, INC. | $96.51 | 2024-2025 | Prolaris, Myrisk |
| Biotissue Holdings INC. | $93.94 | 2025 | |
| Astellas Pharma US INC | $86.54 | 2023-2025 | Xtandi |
| Tolmar, INC. | $81.47 | 2023-2025 | Eligard, Jatenzo |
| Endo USA, INC. | $80.88 | 2024-2025 | Xiaflex |
| Coloplast Corp | $77.63 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67.75 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.90 | 2023-2025 | |
| Axonics, INC. | $46.24 | 2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $44.55 | 2023 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $33.64 | 2025 | Keytruda Qlex, Keytruda |
| Srs Medical Systems, INC. | $28.86 | 2023-2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit, Urocuff |
| Lsi Solutions INC | $24.91 | 2023 | Running Device |
| Photocure INC | $23.94 | 2025 | Cysview |
| Antares Pharma, INC. | $23.35 | 2025 | Xyosted |
| Calyxo, INC. | $22.83 | 2024 | Cvac Aspiration System |
| Avation Medical, INC. | $18.93 | 2025 | Vivally System |
| 180 Medical, INC. | $17.08 | 2023 | |
| Immunitybio, INC. | $15.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Brockman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.